PharmaShots | Incisive News in 3 Shots

Subscribe Now

cognition therapeutics

Cognition Therapeutics Reports P-II Study (SEQUEL) Results of CT1812 for Mild-to-Moderate Alzheimer’s Disease in Netherlands

Cognition Therapeutics Reports P-II Study (SEQUEL) Results of CT1812 for Mild-to-Moderate Alzheimer’s Disease in Netherlands

June 29, 2023

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us